Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share (RGLS)

CUSIP: 75915K309

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
+1,630,086
Put/Call ratio
0.15%
SEC-reported price per share
$1.47
Number of holders
21
Value change
+$2,407,893
Number of buys
10
Open additional details 1 more signal available
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
66,505,186

Security key

75915K309

Report period

Q2 2023

Institutions

21

Top holders

10

Ownership snapshot

Top reported holders of RGLS - Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
21
Shares
8,228,751
Rows available
21
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
22
Q2 2023 holders
21
Holder diff
-1
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .